WMSA
VIVO

Weiss Multi-Strategy Advisers’s Meridian Bioscience Inc VIVO Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-9,340
Closed -$204K – 980
2014
Q1 		$204K Buy
+9,340
New +$214K ﹤0.01% 912

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return
PIM
Perkins Investment Management Chicago, Illinois $8.09B AUM 25.47% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Weiss Multi-Strategy Advisers's VIVO Position: Q2 2014 in Review

Weiss Multi-Strategy Advisers sold out of Meridian Bioscience Inc (VIVO) in Q2 2014, closing a stake of 9,340 shares — an estimated $204K sold.

Weiss Multi-Strategy Advisers first reported a position in VIVO in Q1 2014 and held it in 1 quarter. The position peaked at $204K in Q1 2014. 161 funds tracked by Wall St. Rank hold VIVO as of Q2 2014.

  • Weiss Multi-Strategy Advisers reported no remaining Meridian Bioscience Inc position as of Q2 2014 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 9,340 Meridian Bioscience Inc shares in Q2 2014, an estimated $204K.
  • Weiss Multi-Strategy Advisers first reported a position in Meridian Bioscience Inc in Q1 2014 and held it in 1 quarter.
  • Weiss Multi-Strategy Advisers's Meridian Bioscience Inc position peaked at $204K in Q1 2014.
  • 161 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2014.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2014, filed 14 Aug 2014.